Cell-surface receptor for thyroid hormone and tumor cell proliferation

References

• Bergh JJ, Lin HY, Lansing L et al. Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology146, 2864–2871 (2005).
   PubMed Web of Science ®Google Scholar
• Mousa SA, O’Connor L, Davis FB, Davis PJ. Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology147, 1602–1607 (2006).
   Google Scholar
• Mousa SA, O’Connor LJ, Bergh JJ, Davis FB, Scanlan TS, Davis PJ. The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin.J. Cardiovasc. Pharmacol.46, 356–360 (2005).
   Google Scholar
• Davis FB, Tang HY, Keating T et al. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res.66, 7270–7275 (2006).
   PubMed Web of Science ®Google Scholar
• Dinda S, Sanchez A, Moudgil V. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene21, 761–768 (2002).
   PubMedGoogle Scholar
• Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology145, 3265–3272 (2004).
   PubMed Web of Science ®Google Scholar
• Cao HJ, Tang HY, Shih A et al. Resveratrol induces p53-dependent apoptosis in glioma cells: inhibition of stilbene effect by thyroid hormone. (Manuscript submitted).
   Google Scholar
• Tang HY, Shih A, Lin HY, Davis PJ, Davis FB. Thyroxine induces MAPK activation and blocks resveratrol-induced apoptosis in human thyroid cancer cell lines. Annual Meeting of The Endocrine Society, San Diego, CA, USA, (Abstract) 3–143 (2005).
   Google Scholar
• Lansing L, Davis F, Keating T et al. Enhanced growth of human adenosquamous and small cell lung carcinoma cells directed from the cell surface by thyroid hormone. Annual Meeting of the American Thyroid Association, Phoenix, AZ, (Abstract) 2461 (2006).
   Google Scholar
• Shih A, Zhang S, Cao HJ et al. Disparate effects of thyroid hormone on actions of epidermal growth factor and transforming growth factor-α are mediated by 3´,5´-cyclic adenosine 5´-monophosphate-dependent protein kinase II. Endocrinology145, 1708–1717 (2004).
   PubMed Web of Science ®Google Scholar
• Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J. Clin. Oncol.21, 2787–2799 (2003).
   PubMed Web of Science ®Google Scholar
• Oliveira S, van Bergen en Henegouwen PM, Storm G, Schiffelers RM. Molecular biology of epidermal growth factor receptor inhibition for cancer therapy. Expert Opin. Biol. Ther.6, 605–617 (2006).
   PubMed Web of Science ®Google Scholar
• Singh SP, Carter AC, Kydd DM, Costanzo RR Jr. Interaction between thyroid hormone and erythrocyte membranes: competitive inhibition of binding 131I-triiodothyronine and 131I-L-thyroxine by their analogs. Endocr. Res. Commun.3, 119–131 (1976).
   Web of Science ®Google Scholar
• Angel RC, Botta JA, Farias RN. High affinity L-triiodothyronine binding to right-side out and inside-out vesicles from rat and human erythrocyte membrane. J. Biol. Chem.264, 19143–19146 (1989).
   Google Scholar
• Samson M, Osty J, Francon J, Blondeau JP. Triiodothyronine binding sites in the rat erythrocyte membrane: involvement in triiodothyronine transport and relation to the tryptophan transport system T. Biochim. Biophys. Acta1108, 91–98 (1992).
   Google Scholar
• Davis FB, Mousa SA, O’Connor L et al. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ. Res.94, 1500–1506 (2004).
   PubMed Web of Science ®Google Scholar
• Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J. Biol. Chem.275, 21785–21788 (2000).
   PubMed Web of Science ®Google Scholar
• Rucci N, DiGiacinto C, Orru L, Millimaggi D, Baron R, Teti A. A novel protein kinase Cα-dependent signal to ERK1/2 activated by αVβ3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells. J. Cell Sci.118, 3263–3275 (2005).
   Google Scholar
• Illario M, Cavallo AL, Monaco S et al. Fibronectin-induced proliferation in thyroid cells is mediated by αVβ3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals. J. Clin. Endocrinol. Metab.90, 2865–2873 (2005).
   Google Scholar
• Davis PJ, Davis FB, Blas SD. Studies on the mechanism of thyroid hormone stimulation in vitro of human red cell Ca2+-ATPase activity. Life Sci.30, 675–682 (1982).
   Google Scholar
• Cronrath CM, Rao GS, Rao ML. Nuclear triiodothyronine receptor of human adipose tissue. Metabolism37, 196–199 (1988).
   Google Scholar
• Jones KE, Brubaker JH, Chin WW. Evidence that phosphorylation events participate in thyroid hormone action. Endocrinology134, 543–548 (1994).
   Google Scholar
• Selmi S, Samuels HH. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation. J. Biol. Chem.266, 11589–11593 (1991).
   PubMedGoogle Scholar
• Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ. Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am. J. Physiol.276, C1014–C1024 (1999).
   PubMed Web of Science ®Google Scholar
• Incerpi S, Luly P, De Vito P, Farias RN. Short-term effects of thyroid hormones on Na/H antiport in L-6 myoblasts: high molecular specificity for 3,3´,5-triiodo-L-thyronine. Endocrinology140, 683–689 (1999).
   PubMed Web of Science ®Google Scholar
• D’Arezzo S, Incerpi S, Davis FB et al. Rapid nongenomic effects of 3,5,3´-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways. Endocrinology145, 5694–5703 (2004).
   Google Scholar
• Xiong JP, Stehle T, Diefenbach B et al. Crystal structure of the extracellular segment of integrin αVβ3. Science294, 339–345 (2001).
   PubMed Web of Science ®Google Scholar
• Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol. Rev.81, 1097–1142 (2001).
   PubMed Web of Science ®Google Scholar
• Zhang J, Lazar MA. The mechanism of action of thyroid hormones. Annu. Rev. Physiol.62, 439–466 (2000).
   PubMed Web of Science ®Google Scholar
• Kinugawa K, Jeong MY, Bristow MR, Long CS. Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor α1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase. Mol. Endocrinol.19, 1618–1628 (2005).
   Google Scholar
• Koenig R. Thyroid hormone receptor coactivators and corepressors. Thyroid8, 703–713 (1998).
   PubMed Web of Science ®Google Scholar
• Lin HY, Zhang S, West BL et al. Identification of the putative MAP kinase docking site in the thyroid hormone receptor-β1 DNA-binding domain: functional consequences of mutations at the docking site. Biochemistry USA42, 7571–7579 (2003).
   PubMedGoogle Scholar
• Lin HY, Hopkins R, Cao HJ et al. Acetylation of nuclear hormone receptor superfamily members: thyroid hormone causes acetylation of its own receptor by a mitogen-activated protein kinase-dependent mechanism. Steroids70, 444–449 (2005).
   PubMed Web of Science ®Google Scholar
• Fu M, Rao M, Wu K et al. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. J. Biol. Chem.279, 29436–29449 (2004).
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhang M, Pestell R, Curran EM, Welshons WV, Fuqua SA. Phosphorylation of estrogen receptor α blocks its acetylation and regulates estrogen sensitivity. Cancer Res.64, 9199–9208 (2004).
   PubMedGoogle Scholar
• Zhu XG, Hanover JA, Hager GL, Cheng Sy. Hormone-induced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera. J. Biol. Chem.273, 27058–27063 (1998).
   PubMed Web of Science ®Google Scholar
• Maruvada P, Baumann CT, Hager GL, Yen PM. Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J. Biol. Chem.278, 12425–12432 (2003).
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen PL, Chen CF, Sharp ZD, Lee WH. Thyroid hormone, T3-dependent phosphorylation and translocation of Trip230 from the Golgi complex to the nucleus. Proc. Natl Acad. Sci. USA96, 4443–4448 (1999).
   PubMedGoogle Scholar
• Lin HY, Martino LJ, Wilcox BD, Davis FB, Gordinier JK, Davis PJ. Potentiation by thyroid hormone of human IFN-γ-induced HLA-DR expression. J. Immunol.161, 843–849 (1998).
   Google Scholar
• Shih A, Lin HY, Davis FB, Davis PJ. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry USA40, 2870–2878 (2001).
   PubMedGoogle Scholar
• Davis PJ, Shih A, Lin HY, Martino LJ, Davis FB. Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J. Biol. Chem.275, 38032–38039 (2000).
   PubMed Web of Science ®Google Scholar
• Kato Y, Ying H, Willingham MC, Cheng Sy. A tumor suppressor role for thyroid hormone β receptor in a mouse model of thyroid carcinogenesis. Endocrinology145, 4430–4438 (2004).
   PubMed Web of Science ®Google Scholar
• Vellon L, Menendez JA, Lupu R. αVβ3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. Oncogene24, 3759–3773 (2005).
   PubMed Web of Science ®Google Scholar
• Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. CYR61, a product of growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA95, 6355–6360 (1998).
   PubMed Web of Science ®Google Scholar
• Mousa SA, Feng X, Davis FB, Mohamed S, Scanlan TS, Davis PJ. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model. Int. Angiology (In Press) (2006).
   Google Scholar
• Barnard JCV, Williams AJ, Rabier B et al. Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis. Endocrinology146, 5568–5580 (2005).
   Google Scholar
• Huang CJ, Geller HM, Green WL, Craelius W. Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes. J. Mol. Cell. Cardiol.31, 881–893 (1999).
   Google Scholar
• Sakaguchi Y, Cui G, Sen L. Acute effects of thyroid hormone on inward rectifier potassium channel currents in guinea pig ventricular myocytes. Endocrinology137, 4744–4751 (1996).
   Google Scholar
• Storey NM, Gentile S, Ullah H et al. Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc. Natl Acad. Sci. USA103, 5197–5201 (2006).
   Google Scholar
• Hercbergs AA, Goyal LK, Suh JH et al. Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a Phase I/II study. Anticancer Res.23, 617–626 (2003).
   PubMed Web of Science ®Google Scholar
• Theodossiou C, Skrepnik N, Robert EG et al. Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice. Cancer86, 1596–1601 (1999).
   Google Scholar
• Mishkin SY, Pollack R, Yalovsky MA et al. Inhibition of local and metastatic hepatoma growth and prolongation of survival after induction of hypothyroidism. Cancer Res.41, 3040–3045 (1981).
   Google Scholar
• Short J, Klein K, Kibert L, Ove P. Involvement of the iodothyronines in liver and hepatoma cell proliferation in the rat. Cancer Res.40, 2417–2422 (1980).
   Google Scholar
• Iishi H, Tatsuta M, Baba M, Yamamoto R, Taniguchi H. Enhancement by thyroxine of gastric carcinogenesis induced by N-methyl-N´-nitro-N-nitrosoguanidine in Wistar rats. Br. J. Cancer68, 515–518 (1993).
   Google Scholar
• Esquenet M, Swinnen JV, Heyns W, Verhoeven G. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP. Mol. Cell. Endocrinol.109, 105–111 (1995).
   PubMedGoogle Scholar
• Garcia-Silva S, Perez-Juste G, Aranda A. Cell cycle control by the thyroid hormone in neuroblastoma cells. Toxicology181–182, 179–182 (2002).
   Google Scholar
• Kinoshita S, Sone S, Yamashita T et al. Effects of experimental hyper- and hypothyroidism on natural defense activities against Lewis lung carcinoma and its spontaneous pulmonary metastases in C57BL/6 mice. Tokoshima J. Exp. Med.38, 25–35 (1991).
   Google Scholar
• Ledda-Columbano GM, Perra A, Piga R et al. Cell proliferation induced by 3,3´,5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions. Carcinogenesis20, 2299–2304 (1999).
   Google Scholar
• Gorman CA, Becker DV, Greenspan FS et al. Breast cancer and thyroid therapy. Statement by the American Thyroid Association. JAMA237, 1459–1460 (1977).
   Google Scholar
• Hoffman DA, McConahey WM, Brinton LA, Fraumeni JF Jr. Breast cancer in hypothyroid women using thyroid supplements. JAMA251, 616–619 (1984).
   PubMed Web of Science ®Google Scholar
• Cristofanilli M, Yamamura Y, Kau S-W et al. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer103, 1122–1128 (2005).
   Google Scholar
• Burger AG, Engler D, Sakoloff C, Staeheli V. The effects of tetraiodothyroacetic and triiodothyroacetic acids on thyroid function in euthyroid and hyperthyroid patients. Acta Endocrinol. (Copenh.) 92, 455–467 (1979).
   Google Scholar
• Farwell AP, Tranter MP, Leonard JL. Thyroxine-dependent regulation of integrin-laminin interactions in astrocytes. Endocrinology136, 3909–3915 (1995).
   PubMed Web of Science ®Google Scholar
• Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ et al. Regulation of cerebellar neuronal migration and neurite outgrowth by thyroxine and 3,3´,5´-triiodothyronine. Brain Res. Dev. Brain Res.154, 121–135 (2005).
   PubMedGoogle Scholar
• Leonard JL, Farwell AP. Cytoskeletal actions of iodothryonines. Annual Meeting of The Endocrine Society, Boston, MA, USA (Abstract) S65–S62 (2006).
   Google Scholar
• Trentin AG, De Agular CB, Garcez RC, Alvarez-Silva M. Thyroid hormone modulates the extracellular matrix organization and expression in cerebellar astrocytes: effects on astrocyte adhesion. Glia42, 359–369 (2003).
   Google Scholar
• Cao X, Kambe F, Moeller LC, Refetoff S, Seo H. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K through phosphatidylinositol 3-kinase in human fibroblasts. Mol. Endocrinol.19, 102–112 (2005).
   PubMedGoogle Scholar
• Vokes EE, Chu E. Anti-EGFR therapies: clinical experience in colorectal, lung and head and neck cancers. Oncology (Williston Park)20(5 Suppl. 2), 15–25 (2006).
   PubMedGoogle Scholar
• Lin HY, Lansing L, Merillon JM et al. Integrin αVβ3 contains a receptor for resveratrol. FASEB J.20, 1742–1744 (2006).
   PubMed Web of Science ®Google Scholar